On 9 January 2015 the Swedish Competition Authority cleared the pharmacy merger between ICA and Apotek Hjärtat without conditions after a phase I investigation. RBB worked together with Gernandt & Danielsson, counsel to the acquiring party, on local market analysis which showed that that there was no prospect of substantial lessening of competition. We also analysed pricing strategies and found that there were no incentives for the parties to increase prices following the merger. The full decision is available here.
Our experience and expertise means our clients have the best chance of success before competition authorities and courts.
We have unrivalled experience across the full range of issues presented by competition law and related associated litigation.
